Sustained deep molecular responses in patients switched to nilotinib due to persistent BCR-ABL1 on imatinib: final ENESTcmr randomized trial results

T P Hughes, B Leber, F Cervantes, N Spector, R Pasquini, N C D Clementino, A P Schwarer, P E Dorlhiac-Llacer, F-X Mahon, D Rea, A Guerci-Bresler, S Kamel-Reid, I Bendit, S Acharya, T Glynos, D Dalal, S Branford, J H Lipton

Research output: Contribution to journalArticle

24 Citations (Scopus)
Original languageEnglish
Publication statusE-pub ahead of print - 3 Aug 2017


  • Journal Article

Cite this